Pregnancy after valproate withdrawal-Fetal malformations and seizure control.
Frank J E VajdaTerence J O'BrienJanet E GrahamAlison A HitchcockCecilie M LanderMervyn J EadiePublished in: Epilepsia (2020)
Prepregnancy reduction in VPA dosage reduced the hazard of fetal malformations, whereas ceasing intake of the drug decreased the hazard to one similar to that which applies in the general population, but at a cost of decreased control of epileptic seizures during the pregnancies studied. Further investigations are needed to see whether such findings apply more widely in women with epilepsy.